Skip to main content

CITADEL ADVISORS LLC

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1423053 MIAMI, FL

Position in INBX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$2,229,144 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record

Common Shares in INBX Over Time

Shares Held

Position Value (USD)

Derivatives in INBX

reported options exposure · as of Jun 30, 2026
CallValue
$3,534,175
CallShares
37,300
PutValue
$511,650
PutShares
5,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in INBX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $511,650 5,400
2026-06-30 $3,534,175 37,300
2026-03-31 $2,312,712 34,400
2026-03-31 $242,028 3,600
2026-03-31 $2,229,144 33,157
2025-12-31 $2,125,100 26,900
2025-12-31 $3,460,200 43,800
2025-12-31 $10,854,600 137,400
2025-09-30 $1,926,293 57,194
2025-03-31 $496,645 35,500
2025-03-31 $5,596 400
2024-12-31 $21,560 1,400
2024-12-31 $534,765 34,725
2024-09-30 $90,828 5,800
2024-09-30 $760,684 48,575